Welcome to this issue of The Precedent, which covers those opinions from Q3 and Q4 of 2023 that the Federal Circuit designated as precedential and worthy of publication in the Federal Reporter.
Heron Therapeutics (HRTX) Receives Notice from Mylan Pharmaceuticals Advising Mylan Seeks Approval for Generic Version of APONVIE streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Patent litigation in Q1 2022 remained consistent with long-term trends. In particular, NPE assertion was down compared to an unseasonably active first quarter last year.